In a recent experiment, scientists proved that artificial mouse embryos can be successfully produced from stem cells. An Israel-based biotechnology company announced that they want to test this method on humans. The team, which started working to create an artificial human embryo, announced that they could treat many diseases with synthetic embryos.
Renewal Bio, an Israel-based company founded by Hanna, states that synthetic human embryos will solve many problems. Stating that infertility, genetic diseases and problems related to old age can be solved with this method, Hanna underlined that they will accelerate their work.
Artificial human embryo can be created without sperm and eggs
Scientists in Weizmann’s department of Molecular Genetics published an article in the journal Cell on Aug. According to the published article, the production of synthetic mouse embryos in a jar without the use of sperm and eggs was successfully carried out.
Jacob Hanna, who led the experiment, said, “We didn’t get exactly what we wanted with the replica embryos. That’s why I think our experiment should be developed further. However, we observed stages such as heartbeat, blood circulation and the formation of brain cells in the embryo we created. However, excretory organs, such as the intestine, began to form.” made statements.
Visual impairment becomes a thing of the past! A new method has been discovered
Scientists gave the good news for the biosynthetic corneal implant they have been working on for about 10 years.
Stating that they started working with human cells, Hanna announced that they would first experiment with cells of her own. Some scientists argue that it is still early for synthetic human embryos and that important tests should be performed.
Using human embryo clones for research raises some ethical concerns, according to a 2017 article in the journal eLife. Scientists are worried that emotions such as pain or tenderness may occur in synthetic human embryos.
What do you think about this subject? You can share your ideas in the comments section and on the SDN Forum.